| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/04/2011 | EP2048145B9 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 05/04/2011 | EP1867656B1 Compound having cyclic structure and use thereof |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | EP1373261B1 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | CN1985901B Chinese medicine composition for promoting blood circulation and dredging collaterals and its preparing method and use |
| 05/04/2011 | CN1943681B A Chinese traditional medicinal composition for treatment of child hypophrenia and its preparation method |
| 05/04/2011 | CN1923232B Medicine composition for dispersing pathogenic wind and extinguishing phlegm, absorbing clots and softening hard masses, preparation method and use thereof |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN1500147B Improved gene expression |
| 05/04/2011 | CN102046620A Novel benzothiophene oxide derivative and salt thereof |
| 05/04/2011 | CN102046609A Pyrimidine derivative having cell-protecting activity and use thereof |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/04/2011 | CN102046201A Inhibitor of analgesic tolerance |
| 05/04/2011 | CN102046200A Therapeutic for hepatic cancer |
| 05/04/2011 | CN102046184A Cream-like O/W type emulsified composition and method for producing same |
| 05/04/2011 | CN102046179A Inhibitors of fatty acid amide hydrolase |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102038963A Method for preparing a stabilised menthol emulsion |
| 05/04/2011 | CN102038932A Metal-binding compounds and uses therefor |
| 05/04/2011 | CN102038791A Refreshing liniment |
| 05/04/2011 | CN102038785A Quality control method for traditional Chinese medicinal preparation of children eyesight pills |
| 05/04/2011 | CN102038705A Preparation method of green treatment and health-care liquid medicine |
| 05/04/2011 | CN102038694A Syringin pharmaceutical composition and preparation method and application thereof |
| 05/04/2011 | CN102038673A Application of hydroxyl benzopyrone compound for preparing medicament for treating leukemia |
| 05/04/2011 | CN102038638A Clindamycin hydrochloride injection and preparation method thereof |
| 05/04/2011 | CN102038329A Medicinal insole with blood circulation activation and blood stasis removal functions |
| 05/04/2011 | CN102038191A Application of Chinese date and sealwort composition in preventing anoxia and exhaustion in movement |
| 05/04/2011 | CN102037923A Method for removing toad cortex |
| 05/04/2011 | CN101632748B Medicament for treating night crying of infants and preparation method thereof |
| 05/04/2011 | CN101596261B Medicament for treating hydrocephalus and preparation method thereof |
| 05/04/2011 | CN101428001B Preparation of O/W type medium chain fatty acid microemulsion |
| 05/04/2011 | CN101366949B Method for improving feed efficiency and/or growth rate and/or fat reduction of livestock |
| 05/04/2011 | CN101155600B Radiotherapy enhancer |
| 05/04/2011 | CN101032483B Hydantoin derivative for adjusting estrogen receptor activity and application thereof |
| 05/04/2011 | CN101014580B Morpholine compound |
| 05/03/2011 | USRE42327 Medicinal compositions improving brain function and method for improving brain function |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935718 Treatment of dyskinesia |
| 05/03/2011 | US7935680 Methods for modulating the axonal growth of central nervous system neurons |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935490 Immunodiagnostic assays using reducing agents |
| 05/03/2011 | CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 05/03/2011 | CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
| 05/03/2011 | CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2440438C Heterocyclic compounds |
| 05/03/2011 | CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 05/03/2011 | CA2425933C Combination of catechin and quercetin for pharmaceutical or dietary use |
| 05/03/2011 | CA2378586C Replication-competent anti-cancer vectors |
| 05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
| 05/03/2011 | CA2328485C Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 05/03/2011 | CA2321700C Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 04/28/2011 | WO2011050325A1 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/28/2011 | WO2011049213A1 Fused heterocyclic compound and thrombopoietin receptor activator |
| 04/28/2011 | WO2011049200A1 Antipruritic agent |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048766A1 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases |
| 04/28/2011 | WO2011047597A1 Dihydroxy benzopyranone compounds, medical compositions thereof, and their use for treating and preventing fracture and osteoporosis |
| 04/28/2011 | WO2011021224A3 Improved process for preparing (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-(tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
| 04/28/2011 | US20110099647 Antibodies against cd38 for treatment of multiple myeloma |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098342 Methods of detecting long range chromosomal interactions |
| 04/28/2011 | US20110098318 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/28/2011 | US20110098303 Method of promoting nail growth using thyromimetic compounds |
| 04/28/2011 | US20110098277 Fab I Inhibitors |
| 04/28/2011 | US20110098273 Oligomer-Calcium Channel Blocker Conjugates |
| 04/28/2011 | US20110098259 Pregnane steroids and their use in the treatment of cns disorders |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 04/28/2011 | US20110097404 Tamper-resistant oral opioid agonist formulations |
| 04/28/2011 | US20110097378 Decellularized liver for repair of tissue and treatment of organ deficiency |
| 04/28/2011 | US20110097373 Bone prosthetic material and method of manufacturing the same |
| 04/28/2011 | US20110097338 Use of Substances for Sensitization of Tumor Cells to Radiation and/or Chemotherapy |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097318 Solid-State Protein Formulation |
| 04/28/2011 | US20110097316 Composition to be absorbed through mucous tissue |
| 04/28/2011 | US20110097314 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 04/28/2011 | US20110097313 Method for the Identification and Separation of Non-regulatory T-cells from a Mixture of Regulatory T-cells |
| 04/28/2011 | US20110097309 Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | US20110097274 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (PET) imaging for the brain serotonin transporters |
| 04/28/2011 | US20110097273 Spectral imaging |
| 04/28/2011 | DE102009045899A1 Bismuthaltige Zusammensetzung zur Reduzierung der Phosphatkonzentration in Flüssigkeiten Bismuth-containing composition to reduce the phosphate concentration in fluids |
| 04/28/2011 | CA2777245A1 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/27/2011 | EP2314694A2 BAFF receptor (BCMA), an immunoregulatory agent |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314593A1 Platelet ADP receptor inhibitors |
| 04/27/2011 | EP2314591A1 Pseudopolymorphic forms of a hiv protease inhibitor |
| 04/27/2011 | EP2314586A1 2-Acylaminothiazole derivative or salt thereof |
| 04/27/2011 | EP2314585A1 Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 04/27/2011 | EP2314322A1 Compositions containing genetically modified lung cancer cells expressing a TGF-beta inhibitor |
| 04/27/2011 | EP2314321A1 Formulations comprising antisense nucleotides to connexins |
| 04/27/2011 | EP2314316A1 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 04/27/2011 | EP2314299A1 Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin |